Zijin Gold International Listed on HKEX: Premium Gold Sector Target Poised to Kick Off Investment Feast

HONG KONG, Sep 30, 2025 - (ACN Newswire via SeaPRwire.com) – Since 2024, global gold prices have embarked on a new wave of significant upward momentum, propelling Hong Kong's gold sector into the spotlight for capital pursuit. Related individual stocks have demonstrated remarkable independent performance. Zijin Gold International Company Limited (stock code: 2259.HK), a globally renowned enterprise within the gold sector, officially listed on the Main Board of the Hong Kong Stock Exchange today. It is poised to become a promising new star in the capital market within the gold industry.From a capital market perspective, the successful listing of Zijin Gold International not only offers investors richer investment options but also injects fresh vitality into the market. Amid growing global economic uncertainties, gold's value as a key safe-haven asset has become increasingly prominent. Leveraging its formidable strength and solid reputation in the gold sector, Zijin Gold International is poised to serve as a reliable haven for investors navigating turbulent markets.Meanwhile, the listing will further elevate Zijin Gold International's influence in global capital markets. With the support of a wide range of international investors, the Company is becoming one of the top global gold enterprises, showcasing immense growth potential and broad development prospects.Notably, Zijin Gold International's listing successfully attracted over twenty cornerstone investors, including GIC, Hillhouse, BlackRock, Schroders, Perseverance, Fidelity, and Greenwoods. The active subscriptions from these renowned investment institutions provide robust support for Zijin Gold International's growth trajectory. This not only reflects the strong confidence of leading institutions in the Company's future prospects and growth potential but also offers crucial reference points for investors.A Global Leading Gold Mining Company with Extensive Resource ReservesZijin Gold International is one of the global leading gold mining companies, with operations spanning the entire gold value chain—from exploration and mining to processing, smelting, refining, and sales. The comprehensive industrial chain integration enhances the Company's market competitiveness and resilience against risks.In global resource integration, Zijin Gold International has demonstrated exceptional strength. The Company has strategically positioned itself in gold-rich areas across Central Asia, South America, Oceania, and Africa, holding interests in eight gold mines. As of December 31, 2024 and in 2024, the Company’s gold reserves and gold production volume on a consolidated basis ranked ninth and eleventh globally, respectively. From 2022 to 2024, its gold production achieved a CAGR of 21.4%, achieving a faster growth rate than other sizable companies.These abundant resource reserves provide robust support for the Company's performance growth and sustainable development. From 2022 to 2024, the Company achieved a CAGR of 61.9% in net profit attributable to owners of the parent, demonstrating its strong profitability and growth potential.Furthermore, Zijin Gold International stands as a leading mining company in terms of growth, operational efficiency and profitability in the global gold mining industry. Both the Guyana Aurora Gold Mine and the Suriname Rosebel Gold Mine turned profitable within one year after the Company’s acquisitions in 2020 and 2023, respectively. The Company maintained high capital return in 2024, with ROE of 21.4%, further validating its exceptional capabilities in asset operation and value creation.Strong Shareholder Background Provides Solid FoundationZijin Gold International benefits from a robust shareholder background, with its rapid development supported by the strong backing and synergistic collaboration of Zijin Mining Group. The Company's controlling shareholder, Zijin Mining, is a global leading mining company primarily focused on mineral exploration and development. Zijin Mining operates over 30 large mining projects across 17 countries worldwide as of December 31, 2024, covering metals including gold, copper, lithium, and zinc, among others.Meanwhile, Zijin Mining has extensive experience in the exploration, construction and operation of large-scale metal mines, complemented by professional and efficient resource acquisition and in-house exploration expertise. Advanced technology and rich experience provide strong support for Zijin Gold International's technological innovation and process improvement.The spin-off listing of Zijin Gold International by Zijin Mining Group is based on strategic transformation and long-term development considerations. Through this spin-off, Zijin Gold International will gain independent production capacity, enabling greater focus on business development in the gold sector and enhancing operational efficiency and management standards.Additionally, the spin-off listing of the gold business will not only further optimize Zijin Mining Group's business structure and enhance the Group's overall value, but also provide Zijin Gold International with broader development prospects and stronger momentum, laying a solid foundation for its sustained growth in the gold industry.Actively Practicing ESG Principles to Contribute to Global Sustainable DevelopmentAgainst the backdrop of global advocacy for sustainable development, ESG has become a crucial benchmark for evaluating corporate value and social responsibility. As a socially responsible enterprise, Zijin Gold International has consistently integrated ESG principles into its operations and development, striving to achieve balanced progress across economic, social, and environmental dimensions.The Company is committed to implementing the "Zijin Model", actively building a responsible ESG framework, and comprehensively advancing sustainable development. In this process, the Company strictly adheres to comprehensive and multi-tiered international ESG standards, such as ISO 14001 and others, ensuring it meets internationally advanced levels in environmental management, social responsibility fulfillment, and corporate governance. At the same time, the Company focuses on risk-oriented environmental management, establishing a robust environmental risk assessment system aimed at minimizing ecological impact while maximizing operational efficiency.Furthermore, Zijin Gold International integrated the ‘‘Dual-Carbon’’ commitment into its core agenda of future development and are dedicated to clean energy solutions. The Tajikistan Jilau/Taror Gold Mines, the Colombia Buriticá Gold Mine, and the Suriname Rosebel Gold Mine had achieved 100% utilization of clean energy in purchased electricity as of June 30, 2025. The Guyana Aurora Gold Mine completed two phases of photovoltaic projects with a total capacity of 18MW in 2024, and the Suriname Rosebel Gold Mine’s 25MW photovoltaic project is under construction.Building on this foundation, Zijin Gold International not only actively fulfills its environmental responsibilities but also places significant importance to corporate social value, continuously enhancing investment in community development, employee growth and occupational health. The Company actively promotes economic development in the regions where it operates and shares benefits with the local communities. For example, the Company's ‘‘Sowing the Future’’ agricultural development program in Colombia has been ongoing for five years. The Company actively promotes the development of the Rosebel Community Fund in Suriname and provided financial support in the areas of education, health, sports, and socio-economic development in 2024.The Company also prioritize occupational safety in its operation. During the track record period, the Company's lost-time injury frequency rate was as low as 0.19 per million work hours. As of the end of 2024, the ISO 45001 Occupational Health and Safety Management System certification coverage rate for all operational sites where the Company has held control for over three years reached 100%.Zijin Gold International's ESG practices have been widely recognized in the regions where it operates. During the track record period, Continental Gold received ‘‘the 2024 Sustainable Development Certification’’, Zeravshan received the ‘‘Outstanding Contribution to Environmental Protection Award’’, among others, fully demonstrating the Company's excellence in environmental, social, and governance performance. Moving forward, Zijin Gold International will continue to uphold sustainable development principles, contributing to the achievement of global sustainable development goals.Overall, Zijin Gold International has successfully entered the new stage of the capital market through its extensive business footprint, robust management team, and abundant resource reserves. For investors, Zijin Gold International's listing not only presents a premium target for sharing in gold price dividends but also offers global investors a highly promising investment opportunity. Riding the wave of gold's primary upward trend, the Company will be poised to navigate challenges and create substantial returns for investors in the future, emerging as a star performer in Hong Kong's gold sector. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
紫金黄金国际正式登陆港交所:控股股东实力强大 高度重视ESG建设

紫金黄金国际正式登陆港交所:控股股东实力强大 高度重视ESG建设

香港,2025年9月30日 - (亚太商訊) - 9月30日,紫金黄金国际(2259.HK)正式在港交所挂牌上市,此次上市不仅是紫金黄金国际发展史上的重要里程碑,标志着公司在全球的影响力迈上了新的台阶,更为全球投资者提供了难得的投资机会。作为紫金矿业的子公司,紫金黄金国际在资源、技术、资金等多方面受益于集团的深度赋能。紫金矿业是一家全球领先的以矿产勘查、开发为主的矿业公司。截至2024年12月31日,紫金矿业在全球17个国家拥有超过30个大型的矿业项目,资源储量和产量、营业收入及利润、资产总值及市值均已进入全球矿业公司前五位。同时,紫金矿业在地质勘探、采选冶炼、环保技术等方面的领先优势,也为紫金黄金国际在资源获取和成本控制方面提供了有力支撑。在可持续发展方面,紫金黄金国际高度重视ESG建设,将可持续发展战略与企业经营深度融合。公司积极构建负责任的ESG框架,严格遵循全面且多层次的国际ESG标准,确保在环境管理、社会责任履行以及公司治理等方面达到国际先进水平。同时,公司建立了完善的环境风险评估体系,旨在最大限度地减少生态影响,不断提高营运效率。此外,紫金黄金国际还将「双碳」承诺纳入公司未来发展核心议程,截至2025年6月30日,塔吉克斯坦吉劳╱塔罗金矿、哥伦比亚武里蒂卡金矿和苏里南罗斯贝尔金矿已实现购买电力的100%清洁能源利用。圭亚那奥罗拉金矿于2024年完成了两期光伏项目,苏里南罗斯贝尔金矿的25MW光伏项目正在建设中。在社会责任方面,紫金黄金国际持续加强对小区建设,积极促进经营所在地区经济发展。例如,公司的哥伦比亚「播种未来」农业发展计划已连续开展五年。公司积极推动发展苏里南罗斯贝尔小区基金会,2024年在教育、健康、体育和社会经济发展领域提供财务支持。紫金黄金国际的ESG实践让公司屡获殊荣,于往绩记录期间,大陆黄金获得「2024可持续发展认证」、泽拉夫尚获得「环保突出贡献奖」等。值得一提的是,紫金黄金国际此次上市,引入超过二十家基石投资者,包括GIC、Hillhouse、BlackRock、Schroders、高毅、富达基金及景林等。多家知名机构的积极认购,彰显市场对公司未来发展潜力的高度认可,亦侧面折射出公司的强大吸引力与投资价值。总之,紫金黄金国际的成功上市,不仅是公司自身发展的新起点,更是公司资本运作与产业布局优化的重要成果。未来,紫金黄金国际将在集团支持下,继续秉持「绿色发展、科技驱动、全球视野」的理念,努力成长为具有全球影响力的黄金标杆企业。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
AEON信贷财务二零二五/二六财年上半年纯利增长37.1%

AEON信贷财务二零二五/二六财年上半年纯利增长37.1%

业绩重点- 受销售额及应收款项持续增长带动,收入增长4.3%至897,100,000港元- 税后溢利增长37.1%至233,600,000港元,减值亏损及减值准备减少12.7%- 成本收入比率由47.0%改善至43.8%- 宣派中期股息每股25.0港仙,派付股息比率为44.8%香港,2025年9月30日 - (亚太商訊) - AEON信贷财务(亚洲)有限公司("AEON信贷财务"或"集团";股份代号:00900)今日公布截至二零二五年八月三十一日止六个月("二零二五/二六财年上半年"或"报告期间")未经审核的中期业绩。尽管香港经济持续面对挑战,于报告期间内,集团收入按年增长4.3%至897,100,000港元,展现了核心业务具韧性,以及为维持销售额及应收款项增长所实施措施的有效性。随着集团持续提升营运效率,成本收入比率由截至二零二四年八月三十一日止六个月("二零二四/二五财年上半年"或"去年同期")的47.0%改善至报告期间的43.8%,未计减值亏损及减值准备前的营运溢利上升11.7%至475,600,000港元。得益于减值亏损及减值准备减少12.7%,集团税后溢利增长37.1%至233,600,000港元(二零二四/二五财年上半年:170,400,000港元)。董事会决议宣布派发中期股息每股25.0港仙(二零二四/二五财年上半年:24.0港仙),派付股息比率为44.8%。为应对充满挑战的经济环境,集团于报告期间对推动销售额及应收款项增长采取了更保守的策略,优先以最大幅度提升信用卡及私人贷款组合的回报,同时降低信贷风险。整体销售额较去年同期增长4.4%,主要受益于信用卡销售额的增长,抵销了因审慎信贷评估而下降的私人贷款销售额。客户贷款及应收款项总额保持上升趋势,由二零二五年二月二十八日至二零二五年八月三十一日期间增加2.7%。为应对香港消费金融市场的信贷违约率高企,集团已实施强而有力的信贷监控措施,以改善客户还款表现,及减轻资产质量的恶化。因此,信贷亏损贷款(即第二阶段及第三阶段应收款项)占客户贷款及应收款项总额的百分比,由二零二五年二月二十八日的4.2%下降至二零二五年八月三十一日的4.0%。集团的营销策略有效降低广告成本,同时维持营销效益及优化资源分配。此外,绿色贷款产品的推出进一步强化集团对环境、社会和管治(ESG)原则的承诺。集团利用永旺生态系统,透过如AEON JCB信用卡优化计划等举措发挥协同效应。资讯科技方面,集团已完成IP联络中心(IPCC)项目以提升电话客服中心营运程序,并计划持续评估以进一步提升效率。展望二零二五/二六财年下半年,集团将重点维持销售及应收款项增长,特别是透过本地及网上交易,同时完善信贷评估与监控流程,以确保可持续的高质量贷款组合。营销策略将侧重于精准行销、大规模促销以及利用奖励措施来扩大市场份额,尤其是在年轻群体中。集团亦将透过增加产生手续费之交易和拓展保险中介业务,实现收入多元化。为提升营运效率,集团计划加速将人工智能工具融入后台营运,如自动化数据处理、信用风险分析等日常工作,以降低营运成本及提高准确性。信用评估和贷款组织者将透过升级的风险导向方法得以加强,旨在甄别优质客户以提供额外信贷。先进模型预期能提升信用评估诈欺的侦测和预测分析能力,从而加快决策过程及优化资源配置。在永旺生态系统内,集团已开展One AEON项目,旨在建立一个用于累积和兑换奖励的综合积分平台。该平台将让顾客能透过 "AEON HK"及潜在合作商户手机应用程式,无缝管理从AEON信用卡及潜在合作商户,尤其永旺百货(香港)有限公司("永旺百货")获得的积分奖励。把积分平台和永旺百货网络整合将提升客户的便利性和弹性,促进信贷与零售服务的参与度及忠诚度。AEON信贷财务董事总经理魏爱国先生表示:"集团在二零二五/二六财年上半年业绩理想,印证了我们在充满挑战的市场环境下的韧性及战略措施的有效执行。适逢集团成立35周年,我们将继续秉持《永旺愿景》及永旺集团三大原则—— ‘携手并进’、‘超越集团及公司界限’及‘建立多层面联系,共创充满笑容的未来’。凭借稳固的财务基础及持续的数码转型,我们具备优势把握信贷金融市场的机遇。我们将透过提供创新及以客户为中心的信贷服务,于下半年继续推动业务增长。"关于AEON信贷财务(亚洲)有限公司(股份代号:00900)AEON信贷财务(亚洲)有限公司为AEON Financial Service Co., Ltd.之附属公司(东京证券交易所编号:8570)及AEON集团旗下公司,成立于1987年,并于1995年在香港联合交易所有限公司主板上市。集团主要从事消费融资业务,包括于香港签发信用卡及提供私人贷款融资、信用卡付款处理服务、保险代理及顾问业务,以及于中国内地从事小额融资业务。详情请浏览公司网址:www.aeon.com.hk。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
AEON Credit Reports 37.1% Increase in Net Profit for 1HFY2025/26

AEON Credit Reports 37.1% Increase in Net Profit for 1HFY2025/26

Results Highlights- Revenue rose by 4.3% to HK$897.1 million, driven by sustained sales and receivables growth- Profit after tax increased by 37.1% to HK$233.6 million, with a 12.7% decrease in impairment losses and impairment allowances- Cost-to-income ratio improved to 43.8% from 47.0%- Declared interim dividend of 25.0 HK cents per share, representing payout ratio of 44.8%HONG KONG, Sep 30, 2025 - (ACN Newswire via SeaPRwire.com) – AEON Credit Service (Asia) Company Limited ("AEON Credit" or the "Group"; Stock Code: 00900) today announced its unaudited interim results for the six months ended 31st August 2025 ("1HFY2025/26" or the "Reporting Period").Despite persisted headwinds in the Hong Kong economy, the Group achieved a 4.3% increase in revenue year-on-year to HK$897.1 million during the Reporting Period, demonstrating the resilience of its core operations and the effectiveness of measures implemented to sustain sales and receivables growth. As the Group continued to enhance its operational efficiency, its cost-to-income ratio improved to 43.8% from 47.0% for the six months ended 31st August 2024 ("1HFY2024/25" or the "Previous Period"), and its operating profit before impairment losses and impairment allowances rose 11.7% to HK$475.6 million. With a decrease in impairment losses and impairment allowances of 12.7%, the Group’s profit after tax increased by 37.1% to HK$233.6 million (1HFY2024/25: HK$170.4 million).The Board has resolved to declare an interim dividend of 25.0 HK cents per share (1HFY2024/25: 24.0 HK cents per share), representing a dividend payout ratio of 44.8%.In response to the challenging economic environment, the Group adopted a more conservative approach to sales and receivables growth, prioritising maximizing returns from its credit card and personal loan portfolios while mitigating credit risk. Overall sales increased 4.4% in 1HFY2025/26 compared with the Previous Period, driven by growth in credit card sales, which offset the decline in personal loan sales resulting from prudent credit assessment. Gross advances and receivables continued an upward trajectory, increasing 2.7% from 28th February 2025 to 31st August 2025. To address the prevailing high credit default rates in Hong Kong consumer finance market, the Group has implemented robust credit monitoring measures to improve customers’ payment performance and mitigate deterioration in asset quality. Consequently, the percentage of impaired credit (i.e., stage 2 and stage 3 receivables) to gross advances and receivables decreased from 4.2% as of 28th February 2025 to 4.0% as of 31st August 2025.The Group’s marketing strategy effectively reduced advertising costs while maintaining marketing effectiveness and optimising resource allocation. Meanwhile, the launch of Green Personal Loan products further reinforced the Group’s commitment to environmental, social, and governance (ESG) principles. Leveraging the AEON Ecosystem, the Group also capitalised on group synergy through initiatives such as the AEON JCB credit card revamp programme. In information technology, the Group has completed the IP Contact Center (IPCC) project to enhance its call center operations, with ongoing evaluations planned for further efficiency improvements.Looking ahead to the second half of FY2025/26, the Group will focus on sustaining sales and receivables growth, particularly through domestic and online transactions, while refining credit assessment and monitoring processes to ensure a sustainable and high-quality asset portfolio. Marketing strategies will emphasise targeted campaigns, mass promotions, and leveraging incentives to expand market share, particularly among younger demographics. The Group will also pursue revenue diversification by increasing fee-generating transactions and expanding its insurance intermediary businesses.To enhance operational efficiency, the Group plans to accelerate the implementation of Artificial Intelligence tools into back-office operations automating routine tasks such as data processing and credit risk analysis to reduce operational costs and improve accuracy. Credit assessment and portfolio management will be enhanced through an upgraded risk-based methodology designed to identify high-quality customers for additional credit. Advanced models are expected to improve fraud detection and predictive analytics for credit assessments, enabling faster decision-making and optimised resource allocation.Within the AEON Ecosystem, the Group has commenced One AEON project to create an integrated bonus point platform for reward accumulation and redemption. The platform will enable seamless management of rewards earned from AEON Cards and prospective partner merchants, notably AEON Stores (Hong Kong) Limited ("AEON Stores"), via the “AEON HK” and partner merchant’s mobile app, enhancing customers convenience and flexibility, and fostering greater engagement and loyalty across both credit and retail services.Mr. Wei Aiguo, Managing Director of AEON Credit, said, "Our robust results in 1HFY2025/26 underscore our resilience and effective execution of strategic initiatives against a challenging market environment. As we celebrate our 35th anniversary, we continue to be guided by the AEON Vision Statement and the Three Principles of the AEON Group: ‘moving forward hand in hand’, ‘transcending the boundaries between groups and companies’, and ‘building multifaceted connections and creating a future full of smiles together.’ Bolstered by a solid financial foundation and ongoing digital transformation, we are well positioned to capitalise on opportunities in the credit finance market. We will continue to drive business growth in the second half of the year by delivering innovative and customer-centric credit services.”About AEON Credit Service (Asia) Company Limited (Stock Code: 00900)AEON Credit Service (Asia) Company Limited, a subsidiary of AEON Financial Service Co., Ltd. (TSE: 8570) and a member of the AEON Group, was set up in 1987 and listed on the Main Board of The Stock Exchange of Hong Kong Limited in 1995. The Group is principally engaged in the finance business, which includes the issuance of credit cards, personal loan financing, card payment processing services and insurance intermediary business in Hong Kong, and microfinance business in Mainland China.For more information, please visit the company’s website at www.aeon.com.hk. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

GEM: Building a Closed-Loop New Energy Circular Economy and Embarking on a New Chapter of Global Growth with its Listing in Hong Kong

HONG KONG, Sep 30, 2025 - (ACN Newswire via SeaPRwire.com) – Driven by the “Dual Carbon” strategy, the new energy industry is experiencing rapid growth, with demand for critical new energy metal such as lithium, nickel, and cobalt continuing to surge. However, the exploitation of upstream mineral resource is constrained by environmental concerns, rising costs, and international geopolitical risks, leading to emerging resource bottlenecks. At the same time, as the warranty periods for power batteries gradually expire, a wave of retired batteries is accelerating. Waste-battery recycling, critical metal regeneration, and battery material remanufacturing are becoming emerging growth drivers across the industry chain.Having cultivated expertise in this field for many years, GEM Co., Ltd. (“GEM”, 002340.SZ) has been consistently expanding its presence in the circular economy. The Company has established an integrated circular economy operation model that covers three key businesses: critical metal resources, lithium-ion battery and end-of-life vehicle recycling, and new energy materials. In several niche material markets, GEM ranks among the global leaders. Recently, the Company submitted a listing application to the Hong Kong Stock Exchange, aiming to achieve dual listing on both A and H shares.Three Key Businesses Form a Closed-loop Circular System, with Technology Enabling “Waste-to-Value”GEM’s uniqueness lies in its full-chain closed-loop model built around the concept of a circular economy: “resource recovery — material remanufacturing — product application”. By organically integrating three key business modules of critical metal resources recycling, power batteries and end-of-life vehicles recycling, and new energy materials, the Company not only achieves efficient resource utilization but also significantly enhances the added value of products.In terms of resource recovery, GEM leverages a global recycling network to carry out large-scale collection and dismantling of various resources, including waste-battery, end-of-life vehicles, and electronic waste. To date, the Company has formed partnerships with over 1,000 automotive companies and battery manufacturers worldwide, establishing a stable raw material recycling network and product sales channels. This not only ensures a steady supply of “Urban Mining” resources such as retired batteries and end-of-life vehicles, but also opens up vast market opportunities for new energy materials, positioning the Company as a central hub in the industry chain with risk-resilience significantly stronger than its peers.In terms of material regeneration, GEM utilizes advanced processes to transform recycled resources into high-purity, high value-added intermediate products and new energy materials. As one of the early adopters of hydrometallurgical technology in the industry, the Company utilized this advanced technology to smelt limonite nickel ore, which could hardly be smelted through traditional pyrometallurgy. The process also enables the efficient smelting of other metal resources associated with laterite nickel ore, enhancing overall economic value while achieving recovery rates of up to 99% for nickel, cobalt, and tungsten. In terms of lithium-ion battery and end-of-life vehicle recycling, GEM has established a dual-track processing model of “cascade utilization + material regeneration”, achieving a recovery rate of 96.5% for lithium metal, significantly exceeding the industry average of 90%. More importantly, through technological innovation, GEM further processes recycled resources into high value-added critical new energy materials such as ternary precursors, cathode materials, and cobalt tetroxide, supplying to global battery manufacturers and vehicle OEMs. This truly achieves a complete closed loop process from recycling to application.GEM’s three core businesses are mutually supportive and closely interconnected. The recycling of critical metals and power batteries jointly provides a stable metal supply for the production of new energy materials. Meanwhile, the materials business extends downstream, supplying to battery manufacturers and achieving value-added transformation. This turns green recycling into a profitable and sustainable industrial chain, creating a competitive barrier that is difficult for industry peers to replicate.Leading in Multiple Segments and Seizing the Future Opportunities with a Global ExpansionLeveraging its technological barriers and industrial synergy advantages, GEM has established a globally leading position across multiple segments, emerging as a frontrunner in the new energy materials and resource recycling sector. According to Frost & Sullivan, GEM ranked first in China in the recycling of nickel, cobalt, tungsten resources in terms of recycling volume in 2024, as well as retired lithium-ion battery recycling volume from third parties. In the field of new energy materials, GEM was the second largest supplier of ternary precursors globally in terms of shipment volume in 2024, capturing a market share of 19.7%. At the same time, with a market share of 37.4%, it became the world’s largest supplier of high-nickel ternary precursors, with the shipment volume of its 8-series and 9-series high-nickel ternary precursor materials ranking first globally. In the cobalt tetroxide sector, the Company ranked second worldwide with a market share of 20.2%.Looking ahead, GEM is embracing multiple market opportunities. The expansion of new energy applications is driving sustained growth in demand for critical new energy metals. According to Frost & Sullivan, from 2024 to 2030, nickel demand in China is expected to rise from 335.5 thousand tons in 2024 to 1,233.7 thousand tons in 2030, with the proportion of recycled nickel increasing from 17.2% to 31.1%; Demand for cobalt and tungsten in China will also grow in tandem, while the proportion of recycled cobalt and recycled tungsten will further increase. In addition, under the wave of retired power batteries, it is expected that by 2030, around 15% of the nickel, cobalt, and lithium required for new power batteries will come from recycling.In the field of new energy materials, driven by emerging sectors such as EVs, 3C electronics, low-altitude aircrafts, and humanoid robots, market demand is expected to grow rapidly. In terms of shipment volume, from 2024 to 2030, the CAGR of lithium-ion battery cathode materials is expected to reach 24.2% while that of ternary precursors is projected at 21.6%. Among them, the penetration rate of high-nickel ternary precursors is expected to rise from 35.2% to 70.0%, and the shipment volume of cobalt tetroxide is expected to record a CAGR of 12.7%.Confronting opportunities, GEM has formulated a clear development strategy. On the technology front, it plans to establish overseas R&D centers, increase R&D investment, and deepen the deployment of cutting-edge technologies in the field of new energy materials. On the capacity front, it will expand and upgrade existing production capacity, advance the expansion of its Indonesian base, and strengthen the “nickel resources — precursors — cathode materials” integrated nickel industrial chain. On the globalization front, it intends to set up marketing centers in Japan, South Korea, and Indonesia, enhance customer collaboration, and further expand its global business footprint.GEM’s proposed listing in Hong Kong will provide GEM with broader access to capital and international markets, injecting stronger momentum into its dual growth engines of circular economy and new energy materials. Backed by robust technological barriers, a mature closed-loop model, and an expanding global footprint, the Company is well-positioned to maintain its leading edge in the circular economy sector and unlock greater growth flexibility. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Golden Leaf International Group Limited Announces Listing Plan On GEM Of Hong Kong Stock Exchange

Golden Leaf International Group Limited Announces Listing Plan On GEM Of Hong Kong Stock Exchange

Investment Highlights:- Golden Leaf International is an established E&M (Electrical and Mechanical) engineering contractor with almost 20 years of extensive industry experience, specializing in supply, installation and maintenance of HVAC systems which contributes to over 90% of the Group’s revenue.- For each of the past two financial years, the Group completed over 1,000 projects at different scales. As at 31 July 2025, the Group had 187 projects on hand with backlog value of approximately HK$62.8 million. In addition, the Group has renewed a project for a term of three years commencing from September 2025 with a contract sum expected to be no less than HK$50 million.- For the year ended 31 March 2025, the Group’s revenue increased by approximately 25.6% year-on-year to approximately HK$154.5 million, and the Group’s profit for the year increased by approximately 35.7% to approximately HK$14.1 million. For the year ended 31 March 2025, the Group’s gross profit margin and net profit margin were approximately 20.4% and 9.1%, respectively.- The Group has established business relationships as a main contractor with a wide range of sizeable property managers, reinforcing its solid market position.- The management team has extensive experience in the E&M engineering industry, with Executive Directors boasting over 20-30 years of industry experience.- The Group has developed a cloud-based and customized system “GL ERP” to facilitate efficient project management.- The Group has implemented strict operation systems complying with international standards and certified with ISO 9001:2015 (Quality Management), ISO 14001:2015 (Environmental Management) and ISO 45001:2018 (Occupational Health and Safety Management).HONG KONG, Sep 30, 2025 - (ACN Newswire via SeaPRwire.com) – Golden Leaf International Group Limited ("Golden Leaf International" or the "Company", together with its subsidiaries, the “Group”), a well-established electrical and mechanical ("E&M") engineering contractor in Hong Kong, today announced its listing plan on GEM of Hong Kong Stock Exchange.Before exercising the Offer Size Adjustment Option, the Company plans to offer 100,000,000 shares, with 90% allocated to the Placing and 10% to the Public Offer, at the Offer Price ranging from HK$0.45 to HK$0.65 per Offer Share, which is expected to raise a fund of approximately HK$45 million to HK$65 million.The Public Offer is expected to commence on 30 September 2025 and close at 12:00 noon on 6 October 2025. The allocation results are expected to be announced on or before 9 October 2025. Trading of the Company's shares on GEM is expected to commence on 10 October 2025 under the stock code 8549, with a board lot size of 5,000 shares.Alliance Capital Partners Limited is the Sole Sponsor for the listing. Alliance Capital Partners Limited and CMBC Securities Company Limited are the Joint Overall Coordinators. Alliance Capital Partners Limited, CMBC Securities Company Limited, China Industrial Securities International Capital Limited, First Shanghai Securities Limited, Patrons Securities Limited, Phillip Securities (Hong Kong) Limited, South China Securities Limited, SPDB International Capital Limited and uSmart Securities Limited are Joint Bookrunners and Joint Lead Managers.Golden Leaf International is an established E&M engineering contractor in Hong Kong with almost 20 years of industry experience, specialising in HVAC systems works, which accounted for over 90% of the Group’s revenue. The Group also undertakes electrical systems works, and plumbing and drainage systems works.For each of FY2023/24 and FY2024/25, the Group completed over 1,000 projects at different scales. For the year ended 31 March 2025, the Group’s revenue increased by approximately 25.6% to approximately HK$154.5 million, and profit for the year increased by approximately 35.7% to approximately HK$14.1 million, compared to the previous financial year. The gross profit margin and net profit margin were 20.4% and 9.1%, respectively, for FY2024/25. As at 31 July 2025, the Group had 187 projects on hand with a backlog value of approximately HK$62.8 million. In addition, the Group has renewed a project for a term of three years commencing from September 2025 with a contract sum expected to be no less than HK$50 million.The Group has maintained many years of business relationships with sizable property managers in Hong Kong. Revenue from the top five customers accounted for approximately 64.5% and 68.1% of the Group’s total revenue for the years ended 31 March 2024 and 2025, respectively.The Group’s project portfolio covers commercial properties across Hong Kong Island, Kowloon and the New Territories, including Olympian City in Tai Kok Tsui, China Hong Kong City in Tsim Sha Tsui, Citywalk in Tsuen Wan, Hang Lung Centre in Causeway Bay, Fashion Walk in Causeway Bay, Peak Galleria at the Peak, AIA Tower in North Point, Metro Harbour Plaza in Tai Kok Tsui, The Center in Central, Taikoo Place in Quarry Bay, AIRSIDE in Kai Tak and the Metropolis Tower in Hung Hom.The Company’s management team is experienced and up-to-date with the development of the E&M engineering industry. Mr. Ip Kam Yik, the Chairman of the Board, Chief Executive Officer, Executive Director and one of the founders of the Company, has over 20 years of experience in the E&M engineering industry. Mr. Lui Kwok Kit, Executive Director and one of the founders of the Company, has over 30 years of experience in the E&M engineering industry with extensive on-the-ground experience.The Group has developed a cloud-based "GL ERP" system to facilitate efficient project management, covering tender preparation and approval, project progress monitoring and financial management. Moreover, the Company has implemented strict operation systems complying with international standards and fully certified with ISO 9001:2015 (Quality Management), ISO 14001:2015 (Environmental Management) and ISO 45001:2018 (Occupational Health and Safety Management).The market size for HVAC works in Hong Kong has shown robust growth, driven by urban renewal, sustainability initiatives, and technological advancements. The private sector has been the dominant driver of this growth, expected to grow at a CAGR of approximately 5.8% from 2025 to 2029 reaching approximately HK$8,318.3 million by 2029, reflecting steady demand for upgrades and smart HVAC technologies.The Company intends to use the net proceeds from the Share Offer as follows: approximately 56.1% to finance up-front costs for new projects; approximately 32.6% for recruiting new staff and leasing an additional office; approximately 1.3% for upgrading the "GL ERP" system; and approximately 10% for general working capital purposes.Media Enquiries:Strategic Financial Relations (China) LimitedMs. Anita CHEUNG Tel: (852) 2864 4827Ms. Coco ZHANG Tel: (852) 2864 4830Ms. Alison YIU Tel: (852) 2864 4897Email: sprg-goldenleaf@sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Bamboos Announces 2025 Annual Results

Bamboos Announces 2025 Annual Results

HONG KONG, Sep 29, 2025 - (ACN Newswire via SeaPRwire.com) – Bamboos Health Care Holdings Limited ("Bamboos" or the "Group", Stock Code: 2293) announced its annual results for the year ended 30 June 2025 (the "Period" or the "Year") on September 30th. The Group's overall business remained stable during the year, continuing its consistent focus on shareholder returns, and declared a final dividend for 2025 of HK1.50 cents per ordinary share.During the Period, the Group's revenue was approximately HK$74.4 million. The revenue from the provision of healthcare staffing solution services was approximately HK$61.7 million, comprising approximately HK$35.2 million from institutional staffing solution services and approximately HK$26.5 million from private nursing staffing services. Other income increased year-on-year to HK$1.6 million. Profit before income tax was approximately HK$22.4 million. Profit attributable to equity holders of the Company for the year amounted to approximately HK$17.5 million. Finance income increased year-on-year to approximately HK$1.6 million for the year. Total assets remained stable, with current assets maintaining a healthy level.Furthermore, during the year, the Group also utilized idle cash balances to acquire SPDR Gold Trust, which is a standalone investment trust and an exchange trade fund which holds gold bullion (the "Acquisitions"), enhancing the efficiency of utilizing the Group's idle cash. The Board considers that the Acquisitions provide the Group with opportunity to balance and diversify its investment portfolio, as well as protecting the Group from currency debasements and inflation in times of uncertainty.As of 30 June 2025, the number of healthcare personnel registered with the Group increased by 7.4% year-on-year to approximately 32,000, from 29,800 in the same period last year. This steadily growing, large, and diverse pool of registered healthcare personnel not only demonstrates the Group's favorable benefits and talent retention rate but will also help the Group further enhance its competitive strength and seize business development opportunities.Actively Advances Integration of 'Technology+Innovation' with Healthcare, New 'Bamboos Health' Ecosystem Holds Broad Development SpaceWith healthcare staffing solutions at its core, Bamboos provides professional, comprehensive, reliable, and customized institutional support services and home care nursing solutions for the Hospital Authority, private hospitals, social welfare organizations, clinics, and research medical institutions. While steadfastly maintaining its core business in recent years, the Group has actively promoted the integration of "Technology + Innovation" with healthcare, continuously optimizing service quality and efficiency, deepening business cooperation, and expanding business scope. By integrating three major service sectors – Preventive Medicine, Chinese and Western Medical Services, and Smart Elderly Care and Age-Friendly Living Solutions – the Group has built a new "Bamboos Health" ecosystem.During the year, the Group also actively utilized its self-owned physical space in Mong Kok, and has established a service platform integrating healthcare, smart home AI elderly care technology, and data – "healtHUB". It has evolved from initially providing healthcare staffing solutions into a health technology ecosystem platform covering the full lifecycle of "Prevention-Treatment-Rehabilitation-Home Care-Smart Elderly Care", providing a one-stop healthcare and smart home service solution empowered by "Technology + Innovation".Given the ongoing trends of population ageing and healthcare manpower shortages, coupled with the broad prospects of the global AI healthcare market, Bamboos' focus on "Technology + Innovation" empowerment and its business coverage of the full lifecycle aligns with healthcare industry development trends. Simultaneously, the Group actively responds to national and government policies, echoing China's "Healthy China 2030" Plan Outline and supporting the development of Hong Kong's Primary Healthcare system. This not only allows multiple business lines to benefit from long-term policy support and access stable government business resources but also creates synergies with other operations, presenting Bamboos Health Care with extensive, stable business demand and medium-to-long-term sustainable growth potential.Ms. Hai Hiu Chu, Chairman and Chief Executive Officer of Bamboos Group, said, "Bamboos will continue to dedicate itself to strengthening and consolidating its core business and becoming a more renowned market leader, while actively seeking new business opportunities, advancing the integration of 'Technology + Innovation' with healthcare, and forming alliances or partnerships with strategic collaborators to pursue greater diversification of the Group's business, supporting Bamboos' sustainable growth and the strategy of maximizing shareholder returns."About Bamboos Health Care Holdings LimitedBamboos Health Care Holdings Limited provides a one-stop healthcare and smart home service solution empowered by "Technology + Innovation". Since its establishment in 2009, the Group has always adhered to the service philosophy of "Care • Competence • Commitment". In recent years, while steadfastly maintaining its core business, the Group has promoted the integration of "Technology + Innovation" with healthcare, continuously optimizing service quality and efficiency, deepening business cooperation, and expanding business scope. By integrating three major service sectors – Preventive Medicine, Chinese and Western Medical Services, and Smart Elderly Care and Age-Friendly Living Solutions – the Group has built a new "Bamboos Health" ecosystem. The Group also actively utilized its self-owned physical space in Mong Kok, establishing a service platform integrating healthcare, smart home AI elderly care technology, and data – " healtHUB". The Group has now evolved from initially providing healthcare staffing solutions into a health technology ecosystem platform covering the full lifecycle of "Prevention-Treatment-Rehabilitation-Home Care-Smart Elderly Care".With healthcare staffing solutions at its core, Bamboos boasts a network of over 32,000 qualified professional healthcare personnel, providing professional, comprehensive, reliable, and customized institutional support services and home care nursing solutions for the Hospital Authority, private hospitals, social welfare organizations, clinics, and research medical institutions. To date, the Group has served over 3,500 nursing homes / rehabilitation centres / clinics. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
百本公布2025全年业绩 积极推进”科技+创新”与医疗健康的融合

百本公布2025全年业绩 积极推进”科技+创新”与医疗健康的融合

香港,2025年9月29日 - (亚太商訊) - 百本医护控股有限公司("百本"或"集团",股份代号:2293)于9月26日宣布截至2025年6月30日止年度("期内"或"年内")业绩。年内总体业务保持稳定,延续连年对股东回报的重视,宣派2025年度末期股息每股普通股1.50港仙。期内,集团收益约为7,440万港元,其中提供医护人手解决方案服务所得的收益约为6,170万港元,机构人手解决方案服务所得收益及私家看护人手配置服务所得收益分别为约3,520万港元及约2,650万港元;其他收入同比增加至为160万港元;除所得税前溢利约2,240万港元;公司权益持有人应占本年度溢利约为1,750万港元;财务收入同比增加至本年度的约160万港元;总资产保持稳定,流动资产维持健康水平。此外,集团年内亦动用闲置现金结余收购单一投资信托及持有金锭的交易所买卖基金,SPDR金ETF("该等收购事项"),提升集团闲置现金的使用效益。董事会相信,该等收购事项可为集团提供平衡及分散投资组合的机会,及抗衡货币贬值及通货膨胀。截至2025年6月30日,集团已登记医护人员数目较去年同期的29,800名同比增加7.4%至约32,000名,稳步增长且庞大而多元化的登记医护人员规模不仅显示集团良好的待遇及人才留存率,并将有助集团进一步增强竞争实力,把握业务发展机遇。积极推进"科技+创新"与医疗健康的融合 全新"百本健康"生态具广阔发展空间以医疗人手解决方案为核心,百本可为医院管理局、私家医院、社福机构、诊所及科研医疗机构提供专业、全面、可靠和客制化的医疗机构支援服务及居家养老医护人手解决方案。近年集团在坚守核心业务的同时,积极推进"科技+创新"与医疗健康的融合,持续优化服务质素和效率、加深业务合作及拓展业务内容,整合预防医学、中西医疗、智慧养老及适老化生活解决方案三大服务板块,构建了全新的"百本健康"生态。年内,集团亦积极利用旺角自购实体空间,现已构建了一个集医疗保健及智慧居家人工智能养老科技和数据的服务平台——"healtHUB",已从最初的提供医护人手解决方案发展成为覆盖"预防-治疗-康复-居家照护-智慧养老"全生命周期的健康科技生态平台,提供"科技+创新"赋能的一站式医疗健康及智慧居家服务解决方案。现时人口老龄化及医疗人手短缺趋势持续,全球AI医疗市场前景广阔,百本聚焦"科技+创新"赋能,业务已覆盖符合医疗健康行业发展趋势的全生命周期。同时,集团积极响应国家及政府政策,呼应国家的《"健康中国2030"规划纲要》,并支持香港政府基层医疗健康系统发展,不仅多项业务受益于政策的长期支持,亦可获得稳定的政府业务资源,并可与其他业务形成协同效应,均可为百本带来广泛、稳定的业务需求及中长期持续增长空间。百本集团主席兼行政总裁奚晓珠小姐表示:"百本将继续致力于加强及巩固核心业务及成为更加知名的市场领导者,同时积极寻求新业务机会,推进‘科技+创新’与医疗健康的融合,与战略合作伙伴结盟或合作以追求提高集团业务的多元化程度,为百本的可持续增长及股东回报最大化的策略提供支持"。关于百本医护控股有限公司百本医护控股有限公司提供"科技+创新"赋能的一站式医疗健康及智慧居家服务解决方案。集团自2009年创立以来,始终秉持"关怀备至"、"专业实干"、"全心全意"的服务理念,近年在坚守核心业务的同时,推进"科技+创新"与医疗健康的融合,持续优化服务质素和效率、加深业务合作及拓展业务内容,整合预防医学、中西医疗、智慧养老及适老化生活解决方案三大服务板块,构建了全新的"百本健康"生态。集团亦积极利用旺角自购实体空间,现已构建了一个集医疗保健及智慧居家人工智能养老科技和数据的服务平台——"healtHUB"。集团目前已从最初的提供医护人手解决方案发展成为覆盖"预防-治疗-康复-居家照护-智慧养老"全生命周期的健康科技生态平台。以医疗人手解决方案为核心,百本拥有超过32,000名合资格专业医护人才网络,可为医院管理局、私家医院、社福机构、诊所及科研医疗机构提供专业、全面、可靠和客制化的医疗机构支援服务及居家养老医护人手解决方案。至今,集团已服务超过3,500家老人院/康复中心/诊所。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
31 Concept Accelerates Next-Gen DPI Leadership With Strategic Acquisition of Xynthor AI

31 Concept Accelerates Next-Gen DPI Leadership With Strategic Acquisition of Xynthor AI

DUBAI, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - 31 CONCEPT (31C), a leading UAE-based cybersecurity innovator, today announced the strategic acquisition of Xynthor AI Software Inc., a Canadian company pioneering AI-native Data Loss Prevention (DLP) solutions. This acquisition strengthens 31C's commitment to advancing Deep Packet Intelligence (DPI), corporate security, and data sovereignty in an AI-centric world.31 Concept & XynthorBy integrating Xynthor's "DLP for AI Era" with 31C's DPI expertise, the combined platform will deliver the most comprehensive AI-aware security solution available. This move addresses the growing need for security systems capable of handling modern AI-driven workflows.Why It MattersThe rise of generative AI tools such as ChatGPT and Claude has outpaced the capabilities of traditional DLP systems, which were built for structured data and static rules. High-profile incidents, including the accidental leakage of proprietary source code by Samsung engineers using ChatGPT, highlight the urgent need for AI-specific safeguards.Misha Hanin, CEO of 31C, emphasized: "The convergence of AI and cybersecurity is the most significant paradigm shift our industry has ever seen. Traditional methods cannot manage the dynamic, context-aware data flows of today's AI environments. Through this acquisition, we are pioneering an entirely new category of AI-native security solutions."Xynthor's Breakthrough TechnologyXynthor brings several unique differentiators:AI Data Guardian: Prevents sensitive information from leaving the organization using NLP-driven detection.Air-Gapped Architecture: Keeps analysis inside the client's environment, ensuring privacy and compliance.Context-Aware Intelligence: Reduces false positives through AI-driven classification and behavioral analysis.Private LLM Protection: Enables safe use of internal large language models without external exposure.Seamless Integration: Works with existing infrastructure while supporting regulations like HIPAA and GDPR.Comprehensive AI-Era PlatformThe integrated platform enhances DPI with real-time policy management, adaptive threat detection, and behavioral analytics. It also streamlines compliance with GDPR, HIPAA, PCI DSS, and upcoming AI governance standards.Boris Heismann, CTO of 31C, stated: "We're not only responding to current demands but anticipating tomorrow's challenges. Combining DPI with AI-native DLP creates a future-ready security platform."Strategic ImpactThe global cost of data breaches averages over $4 million per incident, and AI-driven risks are only increasing. By uniting DPI and AI-native DLP, 31C positions itself as a global leader capable of addressing these critical challenges.This acquisition aligns with 31C's growth strategy, including performance-based incentives tied to Xynthor's product success. Both companies will continue to operate from the UAE and Canada, combining their strengths to accelerate innovation and market expansion.About 31CFounded in the UAE, 31C is a cybersecurity company specializing in Deep Packet Intelligence, corporate security, and data sovereignty. Its innovative approach makes it a trusted partner for enterprises, governments, and regulators worldwide.About Xynthor AIBased in Canada, Xynthor AI develops AI-native security platforms designed to protect organizations using generative AI, ensuring both safety and compliance in the AI era.For more information about 31C's Next Gen DPI solutions, visit https://31c.io.Contact InformationMisha HaninCEOmisha.hanin@31c.ioSOURCE: 31 Concept Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
World’s First Methanol Dual-Fuel PCTC ‘CM HONG KONG’ makes its maiden voyage to Hong Kong

World’s First Methanol Dual-Fuel PCTC ‘CM HONG KONG’ makes its maiden voyage to Hong Kong

HONG KONG, Sep 29, 2025 - 28 September, The world's first 9,300 CEU methanol dual-fuel Pure Car and Truck Carrier (PCTC), "CM HONG KONG", celebrated its maiden voyage with a ceremony in Tsing Yi, Hong Kong. Vice-chairperson of the National Committee of the Chinese People's Political Consultative Conference, Leung Chun-ying, Chief Secretary for Administration of the HKSAR, Chan Kwok-kei, Deputy Director of the Liaison Office of the Central People's Government in the HKSAR, Qi Bin, and Chairman of China Merchants Group Limited, Miao Jianmin, etc. attended the ceremony, with Executive Vice President of China Merchants Group Limited, Deng Renjie, as the master of ceremonies.During the event, a commemorative plaque was presented to the ship's captain. Guests toured the vessel's bridge, crew quarters, and innovative methanol dual-fuel system, witnessing its advancements in low-carbon technology and operational efficiency.Built for China Merchants Energy Shipping (CMES), "CM HONG KONG" is the first large-scale car carrier powered by a methanol dual-fuel system, enabling seamless switching between conventional fuel and methanol. Compliant with IMO Tier III emission standards, it achieves over 70% emissions reduction when using green methanol. The ship, measuring 219.9 meters long and 37.7 meters wide, has a design capacity of 9,300 CEUs, with an actual capacity of up to 9,492 CEUs. Its 78,416-square-meter loading area, equivalent to 11 football fields, features 13 decks, including three adjustable lift decks and three tailored for hydrogen fuel cell vehicles. Dual stern and side ramps boost loading/unloading efficiency by 30%. Safety is enhanced with 156 CCTV cameras and thermal imaging infrared sensors across all decks."CM HONG KONG" embarked on its inaugural China-to-Europe route, unloading vehicles in Hong Kong before heading to Europe. Leveraging Hong Kong's free port status, CMES aims to advance the "green fuel trade + port services" model, fostering economic growth, attracting international vessels for green fuel bunkering, and strengthening Hong Kong's role as a global green maritime hub.Vice-chairperson of the National Committee of the Chinese People's Political Consultative Conference, Leung Chun-ying, delivered a speech at the ceremony.Chief Secretary for Administration of the HKSAR, Chan Kwok-kei, delivered a speech at the ceremony.Chairman of China Merchants Group Limited, Miao Jianmin, delivered a speech at the ceremony. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
World Quantum Summit 2025 Concludes to a Full House: “Quantum Unboxed” Signals the Next Leap in AI and Industry Transformation

World Quantum Summit 2025 Concludes to a Full House: “Quantum Unboxed” Signals the Next Leap in AI and Industry Transformation

SINGAPORE, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - The future arrived today in Singapore as the World Quantum Summit 2025 (WQS) — themed “Quantum Unboxed: Extending the Reach of AI” — concluded at the Sheraton Towers Singapore with a full house attendance filling the ballroom to capacity. The overwhelming turnoutunderscored the growing global appetite for practical quantum solutions that extend the power of artificial intelligence and accelerate its real-world impact.This year’s summit was not a standalone event but the culmination of a three-day intensive journey into the future of computing and intelligence. On 23–24 September, participants took part in a sold-out Executive Workshop on Quantum and AI, which built foundational understanding of quantum principles, emerging architectures, and integration strategies. The final day brought it all together, showcasing how those concepts are now being deployed in industry — from real-world applications to large-scale investment strategies.Unlike traditional conferences focused solely on research or theory, WQS 2025 brought together the entire ecosystem driving quantum innovation forward. The summit featured practitioners representing different quantum approaches, policy makers, venture investors, academics, corporates, researchers, and ecosystem partners — all converging under one roof to chart the path from lab breakthroughs to industry-scale adoption. On the exhibition floor, leading players such as ST Engineering, QBoson, and TM Research & Development showcased quantum - enhanced solutions in optimisation, secure computing, and AI acceleration. Meanwhile, Gold Capital Network Partners — IMGT and IWC Management — hosted curated sessions connecting founders and investors to accelerate funding into quantum ventures poised for growth.A key highlight was the line-up of 19 world-class speakers, each offering cutting-edge insights into how quantum is transforming the AI landscape. Among them were Assoc. Prof. Mile Gu, Deputy Director of the Nanyang Quantum Hub at Nanyang Technological University; Jeremy Woo, Senior Technical Advisor at D-Wave System; Deepak Waghmare, CTO (APJC) of Dell Technologies; Ujjwal Kumar, Principal Architect, Office of the CTO at Microsoft Asia; Dr. Simon See, Senior Director and Global Head of the NVIDIA AI Technology Center; Bruno Aznar Martinez, R&D Software Developer at Keysight Technologies; Raghunath Koduvayur, CEO of RAQS Quantum; Gao Qi, Algorithm Director at QBoson; Ken Chew, CEO and Partner of IWC Management; and Tony Gu, General Partner at NGC Ventures. They were joined by Ong Yongcheng of Insignia Ventures, Dr. Amelia Tan of ST Engineering, Eric Lee of Deloitte Southeast Asia, Atsushi Sugiura of Oxford Quantum Circuits, Hidetoshi Matsumura of Fujitsu Limited, Ray Han of SAP, Duleesha Kulasooriya of Deloitte, Manisha Sharma Kohli of Google, and Simon Lawrie of AWS.Throughout the summit, a clear narrative emerged: quantum computing has moved beyond theory into strategic deployment, offering a powerful multiplier for AI. Industry leaders showcased case studies where quantum-enhanced AI is already delivering breakthrough results — from accelerating molecular simulations and optimising financial portfolios to solving supply chainchallenges previously considered intractable. Discussions highlighted how enterprises are integrating quantum capabilities directly into their AI workflows, achieving dramatic improvements in processing power, speed, efficiency, and cost-to-insight.The summit also reflected the shifting investment landscape. As quantum technologies mature, institutional and venture capital investors are moving rapidly to back companies with commercially viable products and near-term revenue potential. “Quantum is no longer the future — it’s today’s most powerful strategic edge and already seeing some real applications,” said Ken Chew, CEO of IWC Management. “The confluence of quantum and AI and their cross-synergies are powerful and those who integrate it into their AI stack early will potentially define the competitive landscape of the next decade.”By the close of the event, one message was clear: quantum will not replace AI — it will supercharge it. With practitioners, investors, policymakers, and researchers now aligned on the urgency of adoption, the era of practical quantum applications is no longer a distant vision — it is here, and it is redefining howindustries think about computation, intelligence, and innovation.The World Quantum Summit has firmly established itself as Asia’s premier platform for quantum commercialisation, bridging science, industry, and capital to accelerate real-world adoption. With its unique focus on applications over abstraction and its ability to convene the full quantum ecosystem, WQS is not just a conference — it is a catalyst for the next wave of technological transformation.Media Contact:Eric KhooConference Director, TPGI Pte Ltderic.khoo@pinnaclegroup.global+65 8383 2480 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
华领医药宣布中国香港卫生署药物办公室正式受理多格列艾汀新药上市许可申请

华领医药宣布中国香港卫生署药物办公室正式受理多格列艾汀新药上市许可申请

香港卫生署受理多格列艾汀的新药上市许可申请(NDA),多格列艾汀是全球首个获批的葡萄糖激酶激活剂(GKA)基于中国大陆的上市批准,以及强大的III期临床研究和真实世界临床结果,多格列艾汀显示出持久的血糖控制和安全性香港将成为华领医药向东南亚及全球拓展的重要支点上海,2025年9月29日 - (亚太商訊) - 华领医药("公司",香港联交所股份代号:2552)宣布,中国香港特别行政区卫生署已正式受理多格列艾汀(dorzagliatin)的新药上市许可申请(NDA)。多格列艾汀是世界上第一个获批准用于治疗2型糖尿病(T2D)的葡萄糖激酶激活剂(GKA)。此次NDA被受理是华领医药拓展中国大陆以外市场战略的一个重要里程碑,有望将其创新的疾病疗法带给更多亚洲患者,并最终推向全球市场。香港有超过50万人患有糖尿病,亚洲有近2.4亿人患有糖尿病,多格列艾汀的NDA是解决该地区最紧迫的健康挑战之一的重要一步。一款具有全球潜力的首创疗法多格列艾汀于2022年9月获得中国国家药品监督管理局(NMPA)的上市批准,获批两个适应症:1)单独用药治疗未经药物治疗的2型糖尿病患者,可以用于一线治疗;2)在单独使用盐酸二甲双胍血糖控制不佳时,与盐酸二甲双胍联合使用,改善成人2型糖尿病患者的血糖控制。与传统的降糖药物不同,多格列艾汀通过修复人体的葡萄糖传感器--葡萄糖激酶(GK)的功能,直击血糖调节异常的根源。通过恢复葡萄糖敏感性,多格列艾汀有助于维持血糖平衡,并支持疾病的长期管理。在中国开展的两项III期注册临床研究结果显示,多格列艾汀能显著且持续地降低糖化血红蛋白(HbA1c)水平,改善胰岛β细胞功能,降低胰岛素抵抗,同时具有良好的安全性和耐受性。目前正在进行的真实世界研究进一步验证了这些发现,其中部分中期分析结果和数据已在2025年美国糖尿病协会(ADA)科学年会上公布。通往新市场的战略门户作为地区的医疗和金融枢纽,香港地区在糖尿病社区管理中已形成了一套较为完善且行之有效的体系。香港中文大学香港糖尿病及肥胖症研究所的研究成果显示,推行社区为本的公私营协作糖尿管理模式成效显著。香港地区的先进经验对提升糖尿病患者生活质量、控制病情发展及减轻医疗负担具有重要意义,待多格列艾汀在香港获批,也将为产品的糖尿病个性化管理提供更丰富的临床应用经验。香港过去的新药审批制度规定,申请人须向管理局提供由两个或以上认可国家的药物监管机关发出的新药注册证明文件,以及其他规定的相关文件,才能支持该产品的审批上市。但在新设的"1+"机制下,在符合本地临床数据支持等要求,并经本地专家认可新药的适用范围后,只须提交一个(而非原来的两个)参考药物监管机构的许可,便可以在香港申请注册。该制度最早适用于治疗严重或罕见疾病的新药,2024年开始扩展至所有新药。在集团运营和大湾区发展部副总裁曹蓓莉女士的领导下,华领医药积极与香港当地临床专家和监管部门进行了充分且深入的沟通,成为这一政策的早期探路者。华领医药在7月底顺利完成多格列艾汀的新药递交申请,并于9月底正式受理。华领医药创始人兼CEO陈力博士表示:"多格列艾汀在香港的NDA获得受理,不仅是对多格列艾汀临床价值的认可,也是华领医药国际化进程中的重要一步。香港是地区医疗领域的引领者和金融枢纽,其独特的地位使其成为将多格列艾汀的影响力拓展至东南亚及其他地区的理想门户。我们会继续与香港本地医生及合作伙伴携手探索多格列艾汀在糖尿病前期、糖尿病早期治疗和预防等方面的潜力,让全球更多患者能从这一突破性疗法中获益。"多格列艾汀:一款变革性的2型糖尿病治疗药物多格列艾汀于2022年9月在中国大陆获批,并被纳入2024年1月1日正式执行的国家医保药品目录。多格列艾汀可作为新诊断患者的一线单药治疗药物,也可在二甲双胍单独用药血糖控制不佳时与二甲双胍联合使用,用于治疗成人2型糖尿病。与许多其它已获批的口服抗糖尿病药物不同,肾功能不全患者使用该药物无需调整剂量。其作用机制是修复人体的葡萄糖传感器--葡萄糖激酶,恢复葡萄糖敏感性和长期血糖平衡。多格列艾汀可以作用于多个关键器官:刺激胰腺分泌胰岛素、促进肠道分泌GLP-1、调节肝脏中的糖原。这种多靶点的作用方式可以直击2型糖尿病的根源,而非仅仅缓解其症状。此次在香港地区的NDA申请基于两项在中国开展的多格列艾汀单药以及联合二甲双胍治疗 T2D 患者的 III 期注册临床研究结果。两项研究表明,针对新诊断未用药和二甲双胍足量治疗失效的两类2型糖尿病患者,通过修复GK的传感器功能缺陷,多格列艾汀能够持续、有效降低患者的HbA1c水平,显著降低餐后两小时血糖值(PPG),在无低血糖条件下血糖达标率高,具有良好的安全性和耐受性,并且能够持续改善β细胞功能和降低胰岛素抵抗。前瞻性声明本文包含有关华领医药以及产品未来预期、计划和前景的陈述。该等前瞻性陈述仅与本文作出该陈述当日的事件或资料有关,可能因未来发展而出现变动。除法律规定外,于作出前瞻性陈述当日之后,无论是否出现新资料、未来事件或其他情况,我们并无责任更新或公开修改任何前瞻性陈述及预料之外的事件。请仔细阅读本文并理解,由于各种风险、不确定性或其他法定要求我们的实际未来业绩或表现可能与预期有重大差异。关于华领华领医药("本公司")是一家总部位于中国上海的创新药物研发和商业化公司,在美国、中国香港设立了公司。华领医药专注于未被满足的医疗需求,为全球患者开发全新疗法。华领医药汇聚全球医药行业高素质人才,融合全球创新技术,依托全球优势资源,研究开发突破性的技术和产品,引领全球糖尿病医疗创新。公司核心产品华堂宁(R)(多格列艾汀片)以葡萄糖传感器葡萄糖激酶为靶点,提升2型糖尿病患者的葡萄糖敏感性,改善患者血糖稳态失调。2022年9月30日,华堂宁(R)已获得中国国家药品监督管理局(NMPA)的上市批准,用于单独用药或者与二甲双胍联合用药,治疗成人2型糖尿病。对于肾功能不全患者,无需调整剂量,是一款可用于肾功能损伤的2型糖尿病患者的口服降糖药物。详情垂询华领医药网址:www.huamedicine.com投资者电邮:ir@huamedicine.com媒体电邮:pr@huamedicine.com Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin

Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin

Hong Kong Department of Health accepts NDA for dorzagliatin, the world’s first approved glucokinase activator (GKA).Builds on China approval and strong Phase III and real-world clinical results showing durable glucose control and safety.Positions Hong Kong as a strategic gateway for Hua Medicine’s global expansion into Southeast Asia and beyond.SHANGHAI, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (“the Company”, HKEX: 2552) announced that the Department of Health of the Hong Kong Special Administrative Region of China accepted a New Drug Application (NDA) for dorzagliatin, the world’s first glucokinase activator (GKA) approved for the treatment of Type 2 diabetes (T2D).The acceptance of the NDA marks an important milestone in Hua Medicine’s strategy to expand beyond China, bringing its innovative, disease-modifying treatment to more patients across Asia and ultimately to global markets.With more than half a million people living with diabetes in Hong Kong and nearly 240 million across Asia, the NDA represents a significant step toward addressing one of the region’s most urgent health challenges.A first-in-class therapy with global potentialDorzagliatin was approved for marketing by the China National Medical Products Administration (NMPA) in September 2022 for two indications, both to improve blood glucose control for T2D patients, 1) It can be used as mono-treatment for drug-naïve T2D patients, as first-line treatment, 2) When metformin hydrochloride alone has poor blood glucose control, it can be used in combination with metformin hydrochloride. Unlike conventional drugs that manage symptoms, dorzagliatin targets the root cause of blood sugar dysregulation by repairing the function of glucokinase (GK), the body’s glucose sensor. By restoring glucose sensitivity, dorzagliatin helps maintain blood sugar balance and supports long-term disease management.Results from two Phase III registration trials in China demonstrated that dorzagliatin significantly and sustainably lowered HbA1c levels, improved pancreatic β-cell function, and reduced insulin resistance, all while showing strong safety and tolerability. Findings are being further validated in ongoing real-world studies, of which some interim analysis and data were presented at the 2025 American Diabetes Association (ADA) Scientific Sessions.Strategic gateway to new marketsHong Kong has established a comprehensive, community-based system for diabetes management and serves as a medical and financial hub for the region. Research findings from the Hong Kong Diabetes and Obesity Research Institute at The Chinese University of Hong Kong indicate that the implementation of a community-based public-private collaboration model for diabetes management provided significant benefits to the community. The advanced experience in Hong Kong is of great significance for improving the quality of life of diabetes patients, controlling the progression of the disease, and reducing the burden on the healthcare system. Once approved in Hong Kong, it will also provide clinical application of dorzagliation for the personalized management of diabetes.According to Hong Kong's former new drug approval mechanism, applicants were required to submit to the authority new drug registration certificates issued by the drug regulatory agencies of two or more recognized countries, as well as other specified relevant documents, in order to support the approval and marketing of the product. Under the newly established "1+" mechanism, after meeting requirements such as local clinical data support and having the applicable scope of the new drug endorsed by local experts, an applicant only needs to submit the approval from one (instead of the original two) reference drug regulatory authority to apply for registration of the new drug in Hong Kong. This mechanism initially applied to new drugs for the treatment of serious or rare diseases, and has been extended to all new drugs since 2024.Under the leadership of Ms. Beili Cao, Vice President of Department of Corporate Operation and Great Bay Development, Hua Medicine has conducted sufficient and in-depth communications with local clinical experts and regulatory authorities in Hong Kong, and became an early pioneer of this mechanism. The Company filed its application for registration of dorzagliatin in Hong Kong at the end of July, and the application was officially accepted by the end of September.Dr. Li Chen, Founder and Chief Executive Officer of Hua Medicine, said: “Acceptance of dorzagliatin’s NDA in Hong Kong is not only recognition of its clinical value but also a pivotal step in Hua Medicine’s international journey. Hong Kong’s unique position as a regional healthcare leader and financial hub makes it the ideal gateway for expanding dorzagliatin’s reach into Southeast Asia and beyond. We are committed to working with local doctors and partners in Hong Kong to explore dorzagliatin’s potential in both treatment and prevention of prediabetes and early-stage diabetes, ensuring more patients worldwide can benefit from this breakthrough therapy.”Dorzagliatin: A transformative T2D treatmentDorzagliatin was approved in September 2022 in China, and it was included in the country’s National Reimbursement Drug List (NRDL) as of January 1, 2024.Dorzagliatin can be used alone as a first-line therapy for newly diagnosed patients, or together with metformin when blood sugar control is inadequate. Unlike many other approved oral antidiabetes drugs, no dose adjustment is required for patients with kidney impairment. It works by repairing the body’s glucose sensor, glucokinase (GK), restoring glucose sensitivity and long-term blood sugar balance. It acts across key organs—stimulating insulin secretion in the pancreas, boosting GLP-1 secretion in the gut, and regulating glycogen in the liver. This multi-target approach addresses the root cause of Type 2 diabetes, not just its symptoms.The NDA application in Hong Kong is based on the results of two Phase III registration clinical studies conducted in China evaluating the use of dorzagliatin monotherapy and in combination with metformin for the treatment of patients with Type 2 diabetes. Two studies have shown that for two categories of T2D patients—those newly diagnosed and not yet on medication, and those who have failed to respond adequately to metformin therapy— dorzagliatin can sustainably and effectively lower patients' HbA1c levels by repairing defects in the glucose sensor function of GK, significantly reduce postprandial two-hour blood glucose levels (2h-PPG), achieve high glycemic control rates without hypoglycemia, demonstrate good safety and tolerability, and continuously improve β-cell function and reduce insulin resistance.Forward-Looking StatementsThis document contains statements regarding Hua Medicine’s future expectations, plans, and prospects for the Company and its products. These forward-looking statements pertain only to events or information as of the date they are made and may change due to future developments. Unless required by law, we are not obligated to update or publicly revise any forward-looking statements or unexpected events after the date of such statements, regardless of new information, future events, or other circumstances. Please read this document carefully and understand that our actual future performance or results may differ materially from expectations due to various risks, uncertainties, or other legal requirements.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsWebsite: ir@huamedicine.comMediaWebsite: pr@huamedicine.com Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Quantum Solutions to Soar Past 100,000 ETH as Landmark Investment from SIG x ARK x IAM Crowns Japan’s ETH Champion

Quantum Solutions to Soar Past 100,000 ETH as Landmark Investment from SIG x ARK x IAM Crowns Japan’s ETH Champion

TOKYO, Sep 29, 2025 - (ACN Newswire via SeaPRwire.com) – Quantum Solutions Co., Ltd. (Tokyo Stock Exchange Code: 2338.T, “Quantum”) announced its strategic financing initiative on September 26 to issue 44 million shares to a blue-chip investor mix of three heavyweight institutions, providing the necessary permanent capital and network access to position Quantum as a potential frontrunner in the world of Ethereum (ETH) listed strategies and a showcase standout in the Tokyo stock market.For Japanese investors, this represents another significant commitment by leading US capital, following Warren Buffett’s investment in Japan’s five major trading companies. For international investors, it signals that Tokyo’s stock market is an increasingly attractive destination for global capital, welcoming new opportunities for “smart money”.Dream Team of Global Capital Aligns for Quantum, International Demand for Japanese Equities Continues to GrowQuantum’s investor line-up is a market stunner in the emerging field of crypto-linked equities. Susquehanna International Group (SIG), investing via CVI Investments, holds the capital firepower to accelerate Quantum’s ETH accumulation and expand its balance sheet for upcoming fundraising rounds. With a portfolio that includes early investments in ByteDance and Strategy Inc. (NASDAQ: MSTR), SIG is a Tokyo Stock Exchange participant, offering the robust capital infrastructure that analysts consider essential for a successful Digital Asset Treasury (DAT).Cathie Wood affirms her position as the world’s leading investor in crypto-linked equities with ARK Invest’s first direct foray into APAC-listed opportunities. In the US market, ARK has a track record for identifying category leaders such as ETH Treasury Bitmine Immersion Technologies (NYSE: BMNR) and cryptocurrency exchange Coinbase (NASDAQ: COIN). By adding Quantum, Wood extends her expertise to the Tokyo market, bringing visibility to Quantum in front of the global investing audience as the region’s most promising ETH Treasury initiative.The third participant is Hong Kong-based Integrated Asset Management (IAM), led by Mr. TC Yam. As the majority shareholder of Forbes Media, IAM’s cross-sector presence in international finance and media resources bolsters Quantum’s capital depth and reputational standing. Like ARK, IAM makes its first public investment in the Tokyo stock market, signaling growing confidence among global institutional investors in Japan's equity market.The fundraise utilizes convertible bonds and both floating and fixed strike price warrants for a total issuance of approximately 44 million shares, nearly doubling the company’s existing share capital. None of the instruments are priced at a discount, a rarity for DAT fundraises, suggesting that the incoming investors are targeting long-term growth prospects. As of market closing on September 26, the nominal value of the financing round comes to over JPY 26 billion (approx. USD 180 million), with the first tranche valued at JPY 22.1 billion (approx. USD 150 million).First ETH Treasury in Japan — A Differentiated Strategy Offering Long-Term Returns on EquityAccording to research reports by leading investment banks, the key determinants of success for listed Digital Asset strategies are robust access to capital and a team with operational blockchain expertise. Through this fundraising initiative, Quantum taps into fresh sources of capital and aligns with investors of strong reputation, prompting market expectations of long-term backing.Quantum CEO Francis B. Zhou is no newcomer to the Digital Asset industry, as one of the first institutional investors and operators in the blockchain space. In 2018, Zhou acquired the world’s second largest ETH mining facility, based in Jokkmokk, Sweden. Zhou maintains investments in early stage blockchain projects alongside film and IP holdings in his venture investment portfolio, and brings a network of experienced blockchain operators, including Head of Crypto Strategy Donny Chi.Proceeds from Quantum’s financing initiative will be used to accumulate ETH. Although BTC has demonstrated adoption as a store-of-value, ETH is the foundational asset for blockchain applications, enabling companies like Quantum to explore attractive yield-generating opportunities to drive a blend of organic and inorganic growth for the company’s core treasury and balance sheet.The appeal of yield-bearing strategies is supported by data from the US market, which indicates that listed ETH Treasuries trade at a price-to-book multiple of 7.72x, more than 3 times higher than that of listed BTC Treasuries. More remarkably, the price-to-book of ETH Treasuries is trending upwards, increasing by over 20% within the trading month of September, demonstrating that the market expectations continue to strengthen for listed ETH Treasuries as it relates to long-term returns on equity.Zhou and the Quantum Solutions team have a history of exploring growth frontiers, consequently developing industry traction in AI computing, GPU hosting, and IP gaming. This positions the company to pursue unique opportunities beyond overcrowded sectors in Real World Asset (RWA) space to potentially generate more attractive returns.With the fundraise, Quantum’s notional price-to-book multiple is estimated to be less than 30% of the market median. Assuming that the company can reach its fair value, the structure of the fundraise allows the company to rapidly accelerate its capital accumulation to reach the target of 100,000 ETH within the near term, positioning Quantum among the leading ETH Treasury companies globally.Growth Driven Policies in Japan Encourage Prospects for Long-Term Shareholder ValueConsistent government support for the blockchain industry and increasing clarity in regulations are ushering in a more investor-friendly market for Digital Assets in Japan. Whereas the US market already has ETH Treasury companies such as Bitmine (NASDAQ: BMNR) and SharpLink Gaming (NASDAQ: SBET) achieving significant market cap growth as capital market highlights, Japan lacks a similar listed benchmark. Quantum Solutions’ entry fills this gap, opening a new chapter as "Japan’s first”, and creating conditions for capital inflow and renewed market participation.This financing round, nominally valued at approximately USD 180 million, is a landmark in both the Japanese stock market as well as the crypto-linked equities space. Through the combined endorsement of SIG, ARK, and IAM, Quantum not only secures funding but also international validation under a capital structure optimized to maximize long-term shareholder value. High-profile deals of this caliber further Tokyo as an emerging destination for savvy investors. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Mooreast与中国国有基础设施开发龙头——中交集团机电工程局签署战略合作协议

Mooreast与中国国有基础设施开发龙头——中交集团机电工程局签署战略合作协议

上海, 2025年9月29日 - (亚太商讯 via SeaPRwire.com) - 新交所凯利板上市公司 Mooreast Holdings Ltd.(以下简称“Mooreast”或“集团”)今日宣布,已与中国交通建设股份有限公司(“中交股份”)旗下子公司签署《战略合作协议》(“SCA”)。中交股份是中国国有的全球基础设施开发龙头企业。根据该协议,Mooreast与中交机电工程有限公司(“中交机电”)计划携手合作,在中国及全球其他地区共同拓展浮式海上可再生能源及相关海洋工程项目的业务机会。该战略合作将充分发挥中交机电在中国境内的规模化运营、专业能力、资源储备、行业声誉和网络优势,同时结合Mooreast在绿色低碳发展和浮式可再生能源领域(包括海上风电)的技术实力、业绩经验及国际网络。双方还将探索建立海上风电相关产业供应链的机会,提供涵盖工程、采购、施工和安装(EPCI)的综合解决方案。Mooreast与中交机电计划合作推进涉及浮式风能及其他海洋工程项目的工程设计、生产、分装、运输和/或系泊及索具系统、风力发电机、浮式平台及相关组件或设备的安装等项目。尽管这些产品和解决方案的主要市场在中国本土,但鉴于亚洲地区技术水平日益提升及生产成本持续下降,双方也看好海外市场的增长机遇。作为海洋与近海领域系泊与索具系统的专业企业,Mooreast是亚洲唯一一家超高功率锚具设计和制造商。伴随全球浮式风电项目的商业化进程不断加快,公司正持续扩大在欧洲和东北亚的市场布局。Mooreast执行董事兼副主席沈君南先生表示:“我们非常高兴并荣幸能与中交机电这样享有盛誉的企业建立合作。与陆上风电相比,中国的浮式海上风电产业仍有巨大潜力尚待开发。我们期待在不久的将来深化合作,把握国内外市场机遇。”本新闻稿已由公司赞助商大华继显私人有限公司(“赞助商”)审阅。本新闻稿尚未经过新加坡证券交易所有限公司(“SGX-ST”)的检验或批准,SGX-ST 对本新闻稿的内容不承担任何责任,包括其中所载陈述、意见或报告的正确性。赞助商联系人大华继显私人有限公司高级副总裁 Lance Tan先生,地址:83 Clemenceau Avenue, #10-01 UE Square, Singapore 239920,电话:(65) 6590 6881。本新闻稿由WeR1 Consultants Pte Ltd代表Mooreast Holdings Ltd. 发布。关于 Mooreast Holdings Ltd.作为全面系泊解决方案的领导者,Mooreast为近海油气、航运及海上可再生能源行业提供系泊系统的设计、工程、制造、供应与物流、安装及调试等服务。凭借近三十年的经验,Mooreast正将其在系泊解决方案领域的业绩与专业能力应用于浮式可再生能源项目,尤其是浮式海上风电。公司已成功参与日本和欧洲的浮式海上风机开发与原型项目。更多信息,请访问 https://mooreast.com/媒体与投资者联系信息WeR1 Consultants Pte LtdIsaac Tang, mooreast@wer1.net(手机:+65 9748 0688) Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Serving the Belt and Road, Setting a New Benchmark for Education, Tianli International School Breaks Ground in Laos National Administrative Center

Serving the Belt and Road, Setting a New Benchmark for Education, Tianli International School Breaks Ground in Laos National Administrative Center

HONG KONG, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - Tianli International Holdings Limited (“Tianli International”) and Shenzhen Yidatong Group recently held a formal signing ceremony in Hong Kong to launch their strategic partnership. The agreement, signed at 3:00 PM on September 25th, marks the official start of a high-end international school project in the heart of Laos’s National Administrative Center.This collaboration represents far more than a commercial alliance. It is a key milestone in Tianli International’s dual strategic priorities—“Education AI” and “China International Education Going Global”—and a concrete step in response to China’s Belt and Road Education Initiative and the national blueprint China Education Modernization 2035, which calls for “a new era of educational openness.”Under the agreement, the partners will jointly develop a world-class international education complex featuring two flagship schools:Premier British Boarding School, offering a complete UK curriculum and authentic boarding traditions to nurture the next generation of global leaders from Laos and neighboring countries.Lida Chinese International School, centered on China’s national curriculum, this school will provide both general and academic Chinese tracks, establish a direct pathway to China’s top universities, and promote two-way student exchange programs.The signing ceremony drew congratulations from the China Association for Non-Government Education, which praised the project as a pioneering example of Chinese private education expanding abroad. Guests and witnesses attended from China, Laos, France, Malaysia, Gambia, and other countries.Dr. Luo Shi, Chairman and President of Tianli International, stated that the partnership is both a pivotal milestone in the group’s global strategy and a major advance in its “Education AI + China International Education Going Global” initiative. Looking ahead, the two partners plan to explore innovations in smart-campus infrastructure and AI-driven teaching, delivering high-quality, diversified education options to Southeast Asia and the wider world.Media ContactCompany: Tianli Education (HK ) LimitedContact Person: Dr. Brown FengZhaoEmail: zhaofeng@tianlieducation.com Website: https://www.tianlieducation.com/en/about/index.html Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
比优集团(09893.HK)的含”金”量

比优集团(09893.HK)的含”金”量

香港,2025年9月29日 - (亚太商訊) - 港股矿产资源板块近期表现强劲,除了受惠于金价、铜价因减息周期、印度尼西亚大型铜矿停产而创出新高带动外,还有备受市场瞩目的紫金矿业(02899.HK)旗下紫金黄金国际分拆上市的炽热招股反应。市传紫金黄金国际公开发售股份录得孖展超购逾190倍,冻资近4800亿港元。此次全球发售还吸引了包括新加坡政府投资公司(GIC)、高瓴资本在内的超豪华基石投资者阵容。摩根士丹利、瑞银等一众国际投行因应目前市场情况已分别再度调升金价及铜价预测,并对未来的黃金、铜的价格维持上行走势表示乐观。从现货黄金市场表现来看,9月26日亚市早盘时段现货黄金于3739.08美元/盎司附近高位震荡,一度达3757.14美元/盎司,创下新历史高点。而上海期货交易所(SHFE)最活跃的铜期货合约同日亦上涨0.32%,至每吨82420元人民币(约11678.3美元)。紫金黄金国际的IPO热潮与黄金、铜等价格的持续新高,为港股市场上的矿业股表现提供了绝佳的时间窗口。在聚焦板块机会、挖掘潜力标的的过程中,一间尚未被充分关注的企业--比优集团(09893.HK),其潜藏的"含'金'量"正值得深挖。作为港股市场稀缺的"矿山+民爆"概念,比优集团通过差异化经营优势,正逐步进入投资者的视野。其中,集团核心资产--安徽金鼎矿山,依托成熟的提金工艺和稳定的产能,正在成为公司业绩的重要支撑。2025全年财报数据显示,安徽金鼎共生产含金泥约850公斤,含金量约20%,折合纯金产量约170公斤。铜金共生资源亦十分亮眼,2024全年开采77.9万吨铜金矿,平均金品位0.66g/t,铜金精矿加工产出1.91万吨,平均金品位显著提升至16.75g/t,为黄金产能的持续释放奠定了坚实基础。随着金、铜板块关注度的不断提升,兼具独特商业模式与清晰成长路径的比优集团,正迎来价值重估的关键窗口。板块东风已至,价值重估正当时作为港股市场中唯一的民用爆破上市公司,公司已构建起"民爆+矿山"垂直一体化业务格局。2025财年,公司实现营业额16.96亿元人民币,同比增长24.09%;股东应占溢利1.64亿元,同比增长25.20%。在矿业板块热度提升的背景下,此类业务独特、赛道专精的企业更易获得流动性溢价与估值重塑的机会。值得注意的是,比优集团于2025年2月18日成功由创业板转至主板,成为港交所"简化转板机制"实施后的首个案例。这一转变不仅是市场认同度提升的变更,更是公司治理结构、信息披露透明度与投资者基础的一次全面升级。随着国际机构投资者的基础扩大,比优集团自加入主板后,股价取得良好的涨幅。国际股票交易及投资信息平台Simply Wall Street 9月15日发表的《Undervalued Small Caps With Insider Buying In Global For September 2025》文章将公司评选为全球十大被低估的中小盘股,较合理估值存在约42%的折让空间。比优集团引起国际投资机构的注意,除业绩佳、增长潜力大以外,公司的发展策略紧密契合国家政策与区域经济脉络亦是投资价值重点所在。在国内,安徽金鼎项目的产能持续释放,并于2023年入选首批安徽省级绿色矿山企业。同时,西藏天仁项目已于2025年1月获西藏自治区发改委核准,预计2026年底投产;海外业务方面,公司自2017年布局塔吉克斯坦市场,已成为当地最大民爆生产商。这种深耕本土+出海双线布局,合理分散了区域风险。安徽金鼎矿--稳健的"产能压舱石"值得留意的是,根据年报披露,安徽金鼎项目持有黄屯硫铁矿与铜金多金属矿的采矿权,采矿许可证于2016年3月颁发,2043年8月才到期,并可依规延期。2025财年(截至3月31日)数据显示,安徽金鼎项目经营状况稳健,盈利水平持续提升,收入已占总收入近半,成为集团稳定发展的坚实支点。据了解,安徽金鼎的15万吨/年硫精矿焙砂提金选矿技术改造工程项目经一年多的试运行后,相关产能进一步释放。2024财年该项目已实现黄金回收约170公斤;截至2025年1-8月,累计黄金产量已达150公斤,产能持续稳定释放。安徽金鼎凭借稳定的黄金产能、成熟的提金工艺及充足的资源储备,将继续发挥"压舱石"的作用,为集团业绩增长提供坚实保障。2025财年,安徽金鼎项目共生产矿石96.09万吨,其中铜金矿77.91万吨,平均品位金0.66 g/t、铜0.39%;硫铁矿8.11万吨,平均品位硫19.57%、金0.29 g/t;磁铁矿10.08万吨,平均品位铁20.98%、金0.34 g/t。展现出强劲的产能兑现能力。根据John Boyd Mining Consulting(Beijing)Company Limited("博德")审核数据,截至2025年3月31日,安徽金鼎西区金铜矿探明资源量900万吨、推断资源量220万吨。矿石储量方面,西区金铜矿概略储量772万吨,东区硫铁矿概略储量657万吨。充裕的资源储备为产能的长期稳定释放提供了坚实保障。排产计划显示,2026-2035年间,安徽金鼎年矿石产量将基本维持在100万吨水平,其中铜金矿石占比约82%,黄金品位维持在0.67-1.04 g/t区间,保证了黄金产出的连续性与稳定性。与此同时,还要留意其铜、硫铁等的输出,尤其在国际铜价保持在高位运行的预期下,安徽金鼎的利润有望持续提升。来源:公司财报从业绩贡献来看,安徽金鼎矿业项目已然成为比优集团利润增长的核心引擎。过去三年,收入实现跨越式增长,从2亿元快速攀升至8.33亿元,年复合增长率超过60%,收入占比已与集团传统民爆业务相当。同时,安徽金鼎"采矿-选矿-提金"的产业链与集团民爆业务形成协同效应--民爆产品为采矿环节提供爆破支持,有效降低运营成本,进一步强化盈利韧性,持续为集团贡献稳定收益。在国际贵金属价格狂飙,紫金黄金赴港上市所引领的板块"东风"之下,比优集团已具备价值重估的多重催化剂。当下,市场资金开始系统性资金配置于估值落后的黄金资源与工业金属股,这类治理完善、业务可见性强、且具备明确成长路径的中小型企业,有望成为下一阶段资金挖掘的重点目标。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
聚力五载 共创未来 | 上实资本召开2025年度投资人大会

聚力五载 共创未来 | 上实资本召开2025年度投资人大会

香港,2025年9月28日 - (亚太商讯 via SeaPRwire.com) - 9月26日,"聚力五载 共创未来"上实资本2025年度投资人大会在上海、香港两地同步举行。值此上实资本成立五周年之际,各界嘉宾齐聚一堂,既回顾五年来深耕投资的坚实历程,更聚焦 "沪港协同发展"的新机遇——发挥香港国际金融中心优势,未来将进一步深化沪港协同,按照上实集团"立足香港、依托上海,服务国家战略、走国际化道路"的战略定位,共探跨境资本赋能生命健康、环境健康产业的新路径。上实集团董事长冷伟青在致辞中表示,面对科技变革浪潮,上实集团立足香港、依托上海、面向全球,主动拥抱创新,在变革中抢抓机遇,聚焦生命健康、环境健康两大主赛道,推动"科技+金融+产业" 的协同发展。上实资本作为集团基金管理和战略直投平台,过去五年,成功打造"生物医药"基金矩阵,支持香港本地生物科技企业科研成果转化,推动全球优质技术与沪港资本、产业资源融合。未来,上实资本将发挥香港平台链接全球资源,在科技创新领域进一步深化沪港协同,以基金为纽带,助力香港在生命健康、环境健康领域的创新成果落地转化,完善跨境投资链条。图注:上实集团董事长冷伟青致辞上实集团首席金融与投资官、上实资本总裁谷峰在主旨演讲中,回顾了上实资本五年间 "立足上海,联动香港,辐射全球" 的发展脉络。他强调,面对全球产业变革,上实资本将以 "沪港联动" 为核心抓手,通过新基金布局与现有基金扩募,持续强化生命健康、环境健康的投资能力。同时,港股基石投资基金的成立,也精准补齐了沪港两地战略产业领域投资的最后一环。上实资本未来的部署将以国家战略为导向、以集团战略为支撑,强化双平台协同,完善跨境基金矩阵,深化与香港本地资源的合作,助力香港打造国际绿色金融中心与生物医药创新中心,推动资本与产业深度的融合,践行集团 "服务国家战略、走国际化道路" 的核心定位。图注:上实集团首席金融与投资官、上实资本总裁谷峰发表主旨演讲本次大会的重要亮点之一,是 "上实资本科技基金(STC)" 品牌的正式发布。作为上实资本聚焦绿色健康赛道的核心载体,STC 将进一步拓展环保能源、具身智能、低空经济等细分产业赛道。依托香港绿色金融的优势,为科创企业提供"资本 + 生态" 的双重赋能,推动沪港绿色科技项目跨境联动,助力香港打造国际绿色科技投资枢纽。图注:上实资本科技基金(STC)品牌发布为深化沪港两地战略产业协同,上实集团携手国泰海通在大会上签署"沪港战略产业基石投资基金"合作协议。该基金作为上实资本布局沪港跨境投资的关键举措,将重点聚焦"上海战略新兴产业赴港上市前最后一公里的融资"——填补沪港跨境投资链条的空白。基金首期规模与香港合作方参与细节将后续公布,预计将成为香港资本市场服务内地战略产业企业赴港上市的重要桥梁。图注:沪港战略产业基石投资基金签约仪式大会同期签署四项重磅合作协议,其中两项与香港产业发展高度相关:1、上实集团 - Azzurra Capital 合资合作:双方将共同在港设立基金投资平台,聚焦全球绿色科技、环保能源项目,推动全球环境健康领域优质技术与中国产业资源、市场资源,香港资源深度融合。图注:上实集团-Azzurra Capital合资合作签约仪式2、香港生物科技基金扩募:作为上实资本深耕香港生物医药领域的核心基金,本次扩募将进一步加大对香港本地生物科技企业的投资力度,同时联动香港科技大学、香港生物医药创新协会等机构,支持科研成果转化,重点投向基因治疗、创新药研发等细分领域,助力香港建设国际生物医药创新中心。图注:香港生物科技基金扩募及战略合作签约仪式此外,上实环境科技基金、上海生物医药基金二期战略合作协议的签约,也进一步完善了上实资本"人民币基金 + 跨境基金" 的多层次布局,两只基金将与香港生物科技基金、沪港战略产业基石投资基金形成协同,为香港资本市场注入更多优质内地产业标的,持续深化沪港两地资本与产业的联动。图注:上实环境科技基金合作签约仪式图注:上海生物医药基金战略合作暨二期启动仪式大会两场圆桌论坛中,"双城慧话 —— 沪港联动创新发展" 专场尤为引发香港业界关注。论坛由上实资本旗下香港生物科技基金总裁梁卫彬主持,香港生物医药创新协会会长卢毓琳、香港科技大学投资基金负责人姚博文、香港尚至医疗集团资深合伙人张仁宇等嘉宾,围绕"沪港联动新发展"展开深入讨论。嘉宾普遍认为,上实资本此次新基金布局与香港生物科技基金扩募,将为香港产业注入新动能,期待未来与上实资本在科研转化、基金合作、人才交流等方面深化联动。图注:双城慧话 —— 沪港联动创新发展圆桌论坛另一场 "并购论道" 圆桌论坛则聚焦产业整合与价值创造,高盛(中国)、华平投资等机构代表提及,香港作为国际金融中心,并购项目在融资、退出方面可充分借力香港资本市场,进一步释放内地与香港的协同价值。本次大会不仅是上实资本五周年的总结,更是沪港跨境投资生态升级的新起点。未来,上实资本将以生命健康、环境健康为主赛道,持续强化香港平台作用,为香港投资人、企业、科研机构搭建更高效的跨境合作桥梁,共同助力香港打造国际绿色金融中心与生物医药创新中心,实现 "聚力五载、共创沪港产业新未来" 的目标。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication

China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication

SHENZHEN, Sept 28, 2025 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiaries, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by CMS on 22 April 2025 for details) together with its subsidiaries, obtained positive results from the phase 3 clinical trial (the “Trial”) of ruxolitinib cream (the “Product”) in patients with mild to moderate atopic dermatitis (AD) in China.The Trial is a randomized, double-blind, placebo-controlled, multi-centre clinical trial, with 192 patients enrolled in total, aiming to evaluate the safety and efficacy of the Product in patients with mild to moderate AD. The leading institution is Shanghai Dermatology Hospital, and the principal investigator is Professor Shi Yuling.The phase 3 clinical trial of ruxolitinib cream in patients with mild to moderate AD in China met its primary endpoint, demonstrating that a significantly higher proportion of patients treated with ruxolitinib cream achieved IGA (Investigator's Global Assessment) of 0 or 1 with at least two grades of reduction from baseline at week 8, compared with placebo (63.0% vs 9.2%, P
More
康哲药业(867.HK;8A8.SG)创新药磷酸芦可替尼乳膏AD中国三期临床取得积极结果

康哲药业(867.HK;8A8.SG)创新药磷酸芦可替尼乳膏AD中国三期临床取得积极结果

深圳,2025年9月28日 - (亚太商讯 via SeaPRwire.com) - 康哲药业控股有限公司("康哲药业")欣然宣布,旗下德镁医药有限公司("德镁医药",专业聚焦皮肤健康的创新型医药企业,正申请于香港联合交易所有限公司主板独立上市,详见康哲药业日期为2025年4月22日发布的公告)连同其附属公司取得磷酸芦可替尼乳膏("芦可替尼乳膏"或"产品")轻中度特应性皮炎(AD)的中国三期药物临床研究("试验")积极结果。该试验是一项在中国人群开展的随机、双盲、安慰剂对照、多中心的临床研究,共入组192例患者,旨在评估产品治疗轻中度AD的安全性和有效性。该研究组长单位为上海市皮肤病医院,主要研究者为史玉玲教授。产品用于轻中度特应性皮炎的中国三期临床研究成功达到主要终点,即使用芦可替尼乳膏治疗8周,达到研究者整体评估(IGA)评分为0或1分,且较基线改善≥2分的受试者比例,显著高于安慰剂(63.0% vs 9.2%,P
More